Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 17, 2021

BUY
$59.34 - $66.74 $430,571 - $484,265
7,256 New
7,256 $458,000
Q1 2020

May 15, 2020

SELL
$46.4 - $67.43 $473,280 - $687,786
-10,200 Closed
0 $0
Q4 2019

Feb 14, 2020

SELL
$49.21 - $64.19 $5.19 Million - $6.77 Million
-105,500 Reduced 91.18%
10,200 $655,000
Q3 2019

Nov 14, 2019

SELL
$42.77 - $50.71 $2.13 Million - $2.52 Million
-49,697 Reduced 30.05%
115,700 $5.87 Million
Q2 2019

Aug 14, 2019

BUY
$44.62 - $49.34 $7.38 Million - $8.16 Million
165,397 New
165,397 $7.5 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $125B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track First Light Asset Management, LLC Portfolio

Follow First Light Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Light Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on First Light Asset Management, LLC with notifications on news.